Paperpal Prime Logo

Breast Cancer : Impact Factor & More

eISSN: 1880-4233pISSN: 1340-6868

Key Metrics

CiteScore
5.9
Impact Factor
< 5
SNIP
1.21
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Breast Cancer

Breast Cancer Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
Overview
Publisher SPRINGER JAPAN KK
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year1993
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Breast Cancer ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Breast Cancer

Next-generation endocrine therapy in HR+/HER2 - breast cancer: oral SERDs, ER-targeting innovations, and ctDNA-driven ESR1 mutation-guided switching.
  • 7 Aug 2026
  • Breast cancer (Tokyo, Japan)
Cost-effectiveness of mammography-based breast cancer screening in Jordan: a healthcare system perspective.
  • 7 Aug 2026
  • Breast cancer (Tokyo, Japan)
Crossing the milestone: landmark-based conditional survival after first-line CDK4/6 inhibitor therapy in HR+/HER2-metastatic breast cancer.
  • 7 Aug 2026
  • Breast cancer (Tokyo, Japan)
Indocyanine green fluorescence angiography algorithm for determining additional anastomosis in deep inferior epigastric perforator flap for breast reconstruction.
  • 3 Aug 2026
  • Breast cancer (Tokyo, Japan)
PTX3 induces the expression of PD-L1 and promotes breast cancer immune escape.
  • 3 Aug 2026
  • Breast cancer (Tokyo, Japan)
Therapeutic mammoplasty in selected East Asian patients: oncologic safety and cosmetic outcomes.
  • 31 Jul 2026
  • Breast cancer (Tokyo, Japan)
Next-generation endocrine therapy in HR+/HER2 - breast cancer: oral SERDs, ER-targeting innovations, and ctDNA-driven ESR1 mutation-guided switching.
  • 7 Aug 2026
  • Breast cancer (Tokyo, Japan)
Cost-effectiveness of mammography-based breast cancer screening in Jordan: a healthcare system perspective.
  • 7 Aug 2026
  • Breast cancer (Tokyo, Japan)
Crossing the milestone: landmark-based conditional survival after first-line CDK4/6 inhibitor therapy in HR+/HER2-metastatic breast cancer.
  • 7 Aug 2026
  • Breast cancer (Tokyo, Japan)
Indocyanine green fluorescence angiography algorithm for determining additional anastomosis in deep inferior epigastric perforator flap for breast reconstruction.
  • 3 Aug 2026
  • Breast cancer (Tokyo, Japan)
PTX3 induces the expression of PD-L1 and promotes breast cancer immune escape.
  • 3 Aug 2026
  • Breast cancer (Tokyo, Japan)
Therapeutic mammoplasty in selected East Asian patients: oncologic safety and cosmetic outcomes.
  • 31 Jul 2026
  • Breast cancer (Tokyo, Japan)

FAQs on Breast Cancer